Total Payments
$6,746
2024 Payments
$795.55
Companies
15
Transactions
121
Medicare Patients
1,893
Medicare Billing
$298,843
Payment Breakdown by Category
Food & Beverage$4,102 (60.8%)
Other$2,500 (37.1%)
Education$64.54 (1.0%)
Gifts$59.40 (0.9%)
Travel$20.00 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,102 | 115 | 60.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,500 | 2 | 37.1% |
| Education | $64.54 | 2 | 1.0% |
| Gift | $59.40 | 1 | 0.9% |
| Travel and Lodging | $20.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $2,768 | 11 | $0 (2021) |
| Medtronic MiniMed, Inc. | $1,779 | 40 | $0 (2020) |
| Medtronic, Inc. | $1,010 | 21 | $0 (2024) |
| Mannkind Corporation | $395.92 | 13 | $0 (2024) |
| Amphastar Pharmaceuticals, Inc. | $318.79 | 8 | $0 (2024) |
| Lilly USA, LLC | $127.92 | 7 | $0 (2024) |
| Novo Nordisk Inc | $103.03 | 5 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $62.99 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $45.03 | 3 | $0 (2024) |
| RECORDATI_RARE_DISEASES_INC. | $34.56 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $795.55 | 22 | Amphastar Pharmaceuticals, Inc. ($269.82) |
| 2023 | $651.32 | 19 | Medtronic, Inc. ($276.53) |
| 2022 | $386.33 | 10 | Medtronic, Inc. ($318.90) |
| 2021 | $241.91 | 12 | Medtronic, Inc. ($174.27) |
| 2020 | $252.83 | 11 | Medtronic MiniMed, Inc. ($241.31) |
| 2019 | $941.01 | 18 | Medtronic MiniMed, Inc. ($887.21) |
| 2018 | $276.14 | 11 | Medtronic MiniMed, Inc. ($200.81) |
| 2017 | $3,201 | 18 | AbbVie, Inc. ($2,720) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Durable Pump | ||||||
| 09/11/2024 | Amphastar Pharmaceuticals, Inc. | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: GLYCOGENOLYTIC AGENTS | ||||||
| 09/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Cardio-renal | ||||||
| 08/20/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: DIABETES MEDICINE | ||||||
| 08/01/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: DIABETES MEDICINE | ||||||
| 07/31/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $117.38 | General |
| Category: DIABETES MEDICINE | ||||||
| 07/25/2024 | Amphastar Pharmaceuticals, Inc. | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $72.51 | General |
| Category: GLYCOGENOLYTIC AGENTS | ||||||
| 07/10/2024 | Medtronic, Inc. | NA (Device) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: Drug Infusion Systems | ||||||
| 07/09/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $174.80 | General |
| Category: Durable Pump | ||||||
| 06/07/2024 | Amphastar Pharmaceuticals, Inc. | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: GLYCOGENOLYTIC AGENTS | ||||||
| 05/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Endocrinology | ||||||
| 05/14/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Durable Pump | ||||||
| 05/14/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/06/2024 | Amphastar Pharmaceuticals, Inc. | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: GLYCOGENOLYTIC AGENTS | ||||||
| 04/12/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: DIABETES MEDICINE | ||||||
| 03/27/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: DIABETES MEDICINE | ||||||
| 03/13/2024 | Amphastar Pharmaceuticals, Inc. | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: GLYCOGENOLYTIC AGENTS | ||||||
| 03/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Diabetes | ||||||
| 02/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Cardio-renal | ||||||
| 02/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: DIABETES | ||||||
| 02/07/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: DIABETES MEDICINE | ||||||
| 02/01/2024 | Amphastar Pharmaceuticals, Inc. | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $105.51 | General |
| Category: GLYCOGENOLYTIC AGENTS | ||||||
| 12/18/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/14/2023 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: ENDOCRINE AGENT | ||||||
| 11/30/2023 | Amphastar Pharmaceuticals, Inc. | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: GLYCOGENOLYTIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 455 | 965 | $129,954 | $81,370 |
| 2022 | 2 | 455 | 913 | $120,684 | $76,295 |
| 2021 | 3 | 501 | 963 | $113,743 | $73,736 |
| 2020 | 2 | 482 | 888 | $99,712 | $67,441 |
Total Patients
1,893
Total Services
3,729
Medicare Billing
$298,843
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 426 | 897 | $116,354 | $79,726 | 68.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 29 | 68 | $13,600 | $1,644 | 12.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 434 | 856 | $109,284 | $74,879 | 68.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 21 | 57 | $11,400 | $1,416 | 12.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 460 | 894 | $99,644 | $69,082 | 69.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 22 | 22 | $4,699 | $3,540 | 75.3% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 19 | 47 | $9,400 | $1,114 | 11.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 464 | 870 | $96,010 | $64,662 | 67.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 18 | 18 | $3,702 | $2,779 | 75.1% |
About Dr. Mark Stesin, M.D
Dr. Mark Stesin, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Robbinsdale, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1750430823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Stesin, M.D has received a total of $6,746 in payments from pharmaceutical and medical device companies, with $795.55 received in 2024. These payments were reported across 121 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($4,102).
As a Medicare-enrolled provider, Stesin has provided services to 1,893 Medicare beneficiaries, totaling 3,729 services with total Medicare billing of $298,843. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Robbinsdale, MN
- Active Since 01/09/2007
- Last Updated 03/27/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750430823
Products in Payments
- Synthroid (Drug) $1,356
- Minimed 670G System (Device) $999.01
- Minimed 630G (Device) $523.72
- MINIMED 780G (Device) $453.60
- AFREZZA (Drug) $395.92
- BAQSIMI (Drug) $351.23
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $261.50
- InPen (Device) $132.94
- Enlite Sensor (Device) $107.99
- MINIMED 770G (Device) $100.67
- Minimed 530G (Device) $69.44
- Kerendia (Drug) $62.99
- Minimed 770G System (Device) $58.76
- MOUNJARO (Drug) $57.37
- Guardian Connect (Device) $48.57
- Androgel (Drug) $44.76
- Ozempic (Drug) $38.49
- FARXIGA (Drug) $33.48
- FIASP (Drug) $32.27
- JARDIANCE (Drug) $26.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.